CliffBio
small molecule

VERAPAMIL HYDROCHLORIDE

VERAPAMIL HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyExela Pharma Sciences Llc →See this company's full patent-cliff portfolio

Drug detail

Brand nameVERAPAMIL HYDROCHLORIDE
Active ingredientVERAPAMIL HYDROCHLORIDE
Strength10MG/4ML (2.5MG/ML)
Dosage formSOLUTION
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalApril 2018
Marketing statusDISCN

More from Exela Pharma Sciences Llc

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.